J E Nutt
Impact in
-
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
-
- Peptidase Inhibition and Analysis
Papers in
-
- Protease and Inhibitor Mechanisms 7
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- John Lunec (12 shared papers)J.K. Mellon (3 shared papers)J. Kilian Mellon (4 shared papers)P. Rajjayabun (2 shared papers)David E. Neal (3 shared papers)F. CLARK (3 shared papers)Adrian L. Harris (1 shared paper)Khaver Qureshi (1 shared paper)
- Journals
- British Journal of Cancer (5 papers)European Journal of Cancer (2 papers)The Journal of Clinical Endocrinology & Metabolism (1 paper)Clinical Lung Cancer (1 paper)The Journal of Urology (1 paper)
- Partner nations
- United KingdomGermanyItaly
In The Last Decade
J E Nutt
15 papers receiving 398 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 128
- Oncology 111
- Endocrinology, Diabetes and Metabolism 59
- Pulmonary and Respiratory Medicine 78
- Immunology and Allergy 14
Countries citing papers authored by J E Nutt
This map shows the geographic impact of J E Nutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J E Nutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J E Nutt more than expected).
Fields of papers citing papers by J E Nutt
This network shows the impact of papers produced by J E Nutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J E Nutt. The network helps show where J E Nutt may publish in the future.
Co-authors
The 25 scholars most cited alongside J E Nutt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 72 | |
| 2 | 1976 | 59 | |
| 3 | 2004 | 45 | |
| 4 | Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder. | 2001 | 40 |
| 5 | Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer. | 2003 | 40 |
| 6 | 1998 | 37 | |
| 7 | 1991 | 28 | |
| 8 | 2010 | 26 | |
| 9 | 1996 | 21 | |
| 10 | 2009 | 17 | |
| 11 | 2015 | 16 | |
| 12 | 2007 | 10 | |
| 13 | 1976 | 6 | |
| 14 | 1974 | 3 | |
| 15 | 1999 | 1 |
About J E Nutt
J E Nutt is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism, having authored 15 papers that have together received 421 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), Thyroid Disorders and Treatments (3 papers), Peptidase Inhibition and Analysis (2 papers), Lung Cancer Treatments and Mutations (2 papers), Occupational and environmental lung diseases (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Estrogen and related hormone effects (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Cancer Research (128 citations), Oncology (111 citations), Endocrinology, Diabetes and Metabolism (59 citations), Pulmonary and Respiratory Medicine (78 citations) and Immunology and Allergy (14 citations). J E Nutt has collaborated with scholars based in United Kingdom, Germany and Italy. Frequent co-authors include John Lunec, J.K. Mellon, J. Kilian Mellon, P. Rajjayabun, David E. Neal, F. CLARK, Adrian L. Harris, Khaver Qureshi, K O’Toole and R B Clague. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, The Journal of Clinical Endocrinology & Metabolism, Clinical Lung Cancer and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.